News and Trends 14 Nov 2022
InfanDx tackles early detection of hypoxic ischemic encephalopathy
InfanDx AG, a privately held diagnostics company focusing on the development and commercialization of novel diagnostic solutions for newborns, has completed the validation of metabolic biomarker panels for the early…